TABLE 2.

Numbers of the main SARS-CoV-2 variants and mutants diagnosed among the IHU Méditerranée Infection cohort of SARS-CoV-2-infected patients as of 18 August 2021.

Variant/ mutant name	Genotyping approach			Total	% of all genotypes
	Next-generation genome sequencing	Next-generation spike gene fragment sequencing	qPCR
Alpha (B.1.1.7, a.k.a. UK)	3,506	2,220	3,568	9,294	38.44
Marseille-4 (B.1.160)	2,564	45	3,516	6,125	25.33
Delta (B.1.617.2, a.k.a. Indian)	1,406	0	2,707	4,113	17.01
Marseille-2 (B.1.177)	679	6	205	890	3.68
Beta (B.1.351, a.k.a. South African)	204	210	161	575	2.38
20A/8371T (1st period)	488	0	0	488	2.02
20A (1st period)	323	44	0	367	1.52
20C (1st period)	310	0	0	310	1.28
20B (1st period)	290	6	0	296	1.22
20A/15324T (1st period)	176	4	0	180	0.74
Marseille-8 (B.1.1.269)	174	2	0	176	0.73
Marseille-5 (B.1.367)	124	0	0	124	0.51
Marseille-1 (B.1.416)	123	0	0	123	0.51
20A/25563T (1st period)	123	0	0	123	0.51
Marseille-9 (B.1.1.241)	117	0	0	117	0.48
Marseille-484K.V3 (B.1.525)	112	0	0	112	0.46
20A/20268G (1st period)	95	0	0	95	0.39
Marseille-10 (B.1.221)	89	2	0	91	0.38
20A/2416T (1st period)	89	0	0	89	0.37
Gamma (P.1, a.k.a. Brazilian)	70	1	16	87	0.36
Marseille-501 (A.27)	26	48	0	74	0.31
Marseille-452R-19B (A.21)	43	2	0	45	0.19
Marseille-3 (B.1)	39	0	0	39	0.16
19B (1st period)	13	23	0	36	0.15
Marseille-12	36	0	0	36	0.15
20D (B.1.1.1)	31	2	0	33	0.14
20E (B.1.177)	21	0	0	21	0.09
Marseille-484K.V2 (B.1.1.318)	20	1	0	21	0.09
Marseille-11 (B.1.221)	19	0	0	19	0.08
19A (1st period)	15	0	0	15	0.06
B.1.214 (a.k.a. Belgian)	15	0	0	15	0.06
Marseille-7 (B.1416.1)	15	0	0	15	0.06
Marseille-6 (B.1)	9	0	0	9	0.04
Marseille-681R-19B (A.23.1)	7	0	0	7	0.03
Marseille-681H-19B (A.23)	6	0	0	6	0.02
Epsilon (B.1.427/B.1.429)	6	0	0	6	0.02
B.1.621	6	0	0	6	0.02
Marseille-484.V1 (A.23)	3	0	0	3	0.01
Total	11,392	2,616	10,173	24,181	100.0